Shannon Salvador

Dr. Shannon Salvador

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
SSShannon Salvador
Shannon Salvador
BGBlake Gilks
Blake Gilks
MKMartin Köbel
Martin Köbel
DHDavid Huntsman
David Huntsman
BRBarry Rosen
Barry Rosen
DMDianne Miller
Dianne Miller

5 April 2013 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
WSWeiva Sieh
Weiva Sieh
SSShannon Salvador
Shannon Salvador
VMValerie McGuire
Valerie McGuire
RWRachel Palmieri Weber
Rachel Palmieri Weber
KTKathryn L Terry
Kathryn L Terry
AWAlice S Whittemore
Alice S Whittemore
Background Tubal ligation is a protective factor for ovarian cancer, but it is unknown whether this protection extends to all invasive histological subtypes or borderline tumors. We undertook an international collaborative study to examine the association between tubal ligation and ovarian cancer subtypes. Methods We pooled primary data from 13 population-based case-control studies, including 10 157 patients with ovarian cancer (7942 invasive; 2215 borderline) and 13 904 control women. Invasive cases were analysed by histological type, grade and stage, and borderline cases were analysed by histological type. Pooled odds ratios were estimated using conditional logistic regression to match on site, race/ethnicity and age categories, and to adjust for age, oral contraceptive use duration and number of full-term births. Results Tubal ligation was associated with significantly reduced risks of invasive serous (OR, 0.81; 95% CI, 0.74-0.89; P < 0.001), endometrioid (OR, 0.48; 95% CI, 0.40-0.59; P < 0.001), clear cell (OR, 0.52; 95% CI, 0.40-0.67; P < 0.001) and mucinous (OR, 0.68; 95% CI, 0.52-0.89; P = 0.005) cancers. The magnitude of risk reduction was significantly greater for invasive endometrioid (P < 0.0001) and clear cell (P = 0.0018) than for serous cancer. No significant associations were found with borderline serous or mucinous tumours. Conclusions We found that the protective effects of tubal ligation on ovarian cancer risk were subtype-specific. These findings provide insights into distinct aetiologies of ovarian cancer subtypes and mechanisms underlying the protective effects of tubal ligation.

1 September 2008 in Gynecologic Oncology
Verified
Journal Article
Closed access
SSShannon Salvador
Shannon Salvador
ARAllan Rempel
Allan Rempel
JHJoshua Honeyman
Joshua Honeyman
BGBlake Gilks
Blake Gilks
DHDavid Huntsman
David Huntsman
DMDianne Miller
Dianne Miller

1 March 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
JHJeffrey How
Jeffrey How
CGCaroline Gauthier
Caroline Gauthier
JAJeremie Abitbol
Jeremie Abitbol
SLSusie Lau
Susie Lau
SSShannon Salvador
Shannon Salvador
WGWalter Gotlieb
Walter Gotlieb

1 August 2020 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
SSShannon Salvador
Shannon Salvador
SSStephanie Scott
Stephanie Scott
PGPhyllis Glanc
Phyllis Glanc
LELua Eiriksson
Lua Eiriksson
JJJi-Hyun Jang
Ji-Hyun Jang
EDErin Dean
Erin Dean

21 November 2022 in Gynecologic Oncology
Verified
Journal Article
Closed access
EMEmad Matanes
Emad Matanes
ZAZainab Amajoud
Zainab Amajoud
LKLiron Kogan
Liron Kogan
CMCristina Mitric
Cristina Mitric
SISara Ismail
Sara Ismail
WGWalter Gotlieb
Walter Gotlieb